NVO — Novo Nordisk A/S Share News
0.000.00%
Last trade - 00:00- $175.03bn
- $189.31bn
- DKK309.06bn
Brief: Orbis Medicines Enters Drug Discovery Partnership With Novo Worth Up To $1.4 Bln
Novo, Orbis sign up to $1.4 billion deal to develop oral drugs
Novo partners with Anthropic to speed up drug development with Claude
Brief: Novo And Anthropic To Collaborate To Advance Drug Discovery With Claude
Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugs
Brief: Novo To Share Real-World, Clinical Data At EASD 2026
Ascendis Pharma tumbles on Novo Nordisk collab termination
Novo CEO urges staff to embrace more customer-focused culture
Lilly says Foundayo has captured over 30% of new US patients on oral weight-loss drugs
Novo Nordisk rebrands as 'Novo', announces cultural reset
Corrected: UPDATE 3-Scholar Rock gets first FDA nod for rare muscle-wasting disease (September 11)
US FDA approves Scholar Rock's muscle weakness drug
Live Markets: Will Fed's Warsh break with the White House?
Live Markets: European equity investors keep watching gas prices
Live Markets: Some welcome calm for stocks
MS cuts Novo Nordisk on growth prospects, patent expiry risks
Europe Research Roundup: IWG, Londonmetric, Sartorius
Focus: Novartis investors turn spotlight on M&A after trial setbacks
Novo Nordisk says Wegovy approved in China for liver disease MASH (updated)